PF-03382792

DB12949InvestigationalSmall molecule

Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers).

Formula / weight: C₂₃H₃₂FN₃O₄ · 433.524 g/mol (avg)
Code names: PF-03382792

Resolves to

Compound

UNIIQPE81T4KH0CAS1400811-63-3ChEMBLCHEMBL2179582PubChem71451950

Structure

InChIKeyAGMOFKKOVMRGAK-UHFFFAOYSA-NSMILESCC1(C)C(=O)N(C(=O)NCC2CCN(CC3(O)CCOCC3)CC2)C2=CC(F)=CC=C12

What you can answer from here — as of April 02, 2025

2Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of PF-03382792, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account